hAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Leukemia
- Type
- Observational
- Design
- Observational Model: Case-OnlyTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 125 years
- Gender
- Both males and females
Description
Establishment of Clinical Applicable Human Amniotic Epithelial Cell Products and Its Preliminary Application in Allogeneic Hematopoietic Stem Cell Transplantation
Establishment of Clinical Applicable Human Amniotic Epithelial Cell Products and Its Preliminary Application in Allogeneic Hematopoietic Stem Cell Transplantation
Tracking Information
- NCT #
- NCT03759899
- Collaborators
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
- Investigators
- Principal Investigator: Xiaojun Huang Peking University People's Hospital
Get Well Soon